anti-Human TNFRSF10C antibody for Flow Cytometry

Recommended TNFRSF10C Antibody (supplied by: Log in to see )

Antigen
Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) Antibodies
  • CD263
  • DCR1
  • DCR1-TNFR
  • LIT
  • TRAIL-R3
  • TRAILR3
  • TRID
  • TNFRSF10C
  • tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
  • TNFRSF10C
Epitope
AA 1-221
31
15
9
7
6
3
2
1
1
1
1
1
1
1
1
1
Reactivity
Human
153
18
15
7
Host
Mouse
110
47
3
3
Clonality
Monoclonal
Conjugate
This TNFRSF10C antibody is un-conjugated
19
14
5
5
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
Application
Cytometry by Time of Flight (CyTOF), Flow Cytometry (FACS)
91
75
31
23
17
12
7
6
2
2
2
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

Submit your validation data for this product and get a full refund. I want to validate this product

Learn more

Available images

Catalog No. ABIN4899000
Contact our Customer Service for availability and price in your country.
Relevance Score ABIN Application Conjugate Host Isotype Epitope Supplier Clonality References Details
14.327658 ABIN4895308 FACS PE Mouse IgG1 AA 1-221 Log in to see 90906 7
14.327658 ABIN259059 CyTOF FACS Mouse IgG1 AA 1-280 Log in to see TRAIL-R3-02
14.327658 ABIN2663243 FACS PE Mouse IgG1 kappa Log in to see DJR3 3
14.327658 ABIN4895307 FACS Allophycocyanin Mouse IgG1 AA 1-221 Log in to see 90906
14.327658 ABIN301991 FACS Mouse IgG1 AA 1-280 Log in to see TRAIL-R3-02 4
14.327658 ABIN2479552 FACS IP Mouse IgG1 Log in to see 2B8
14.327658 ABIN187537 FACS IF Mouse IgG1 Log in to see HS301
1 ABIN487315 FACS PE Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN487314 FACS FITC Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN1106171 FACS PE Mouse IgG1 Log in to see B-D44 2
1 ABIN238512 FACS Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN1106170 FACS Mouse IgG1 Log in to see B-D44 1
1 ABIN1383917 FACS PE Mouse IgG1 Log in to see B-D44 2
1 ABIN1169230 ICC FACS Mouse IgG1 Log in to see HS301 4
1 ABIN1383918 FACS Mouse IgG1 Log in to see B-D44 1
1 ABIN187538 FACS WB Mouse IgG2a Log in to see LEIA
1 ABIN1169229 FACS IHC Mouse IgG1 Log in to see TR3-06
1 ABIN474545 FACS PE Mouse IgG1, kappa Log in to see DJR3
1 ABIN316544 FACS PE Mouse IgG1 Log in to see 2B8
1 ABIN181101 FACS IP FITC Mouse IgG1 Log in to see 2B8

General

Antigen Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) Antibodies
Epitope AA 1-221
(31), (15), (9), (7), (6), (3), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity Human
(153), (18), (15), (7)
Host Mouse
(110), (47), (3), (3)
Clonality (Clone)
Monoclonal   ( )
Conjugate This TNFRSF10C antibody is un-conjugated
(19), (14), (5), (5), (4), (4), (3), (3), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1)
Application Cytometry by Time of Flight (CyTOF), Flow Cytometry (FACS)
(91), (75), (31), (23), (17), (12), (7), (6), (2), (2), (2), (1), (1), (1)
Pubmed 11 references available
Supplier Log in to see

Product Details anti-TNFRSF10C Antibody

Target Details TNFRSF10C Application Details Handling References for anti-TNFRSF10C antibody (ABIN4899000) Images
Specificity Detects human TRAIL R3/TNFRSF10C in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TRAIL R2, rhTRAIL R1, or rhTRAIL R4 is observed.
Purification Protein A or G purified from hybridoma culture supernatant
Sterility 0.2 μm filtered
Endotoxin Level <0.10 EU per 1 μg of the antibody by the LAL method.
Immunogen Mouse myeloma cell line NS0-derived recombinant human TRAIL R3/TNFRSF10C, Met1-Ala221, Accession # O14798
Clone 90906
Isotype IgG1

Target Details TNFRSF10C

Product Details anti-TNFRSF10C Antibody Application Details Handling References for anti-TNFRSF10C antibody (ABIN4899000) Images back to top
Antigen
Alternative Name TRAIL R3/TNFRSF10C (TNFRSF10C Antibody Abstract)
Background Alternative Names: Antagonist decoy receptor for TRAIL/Apo-2L, CD263, CD263 antigen, cytotoxic TRAIL receptor-3, DcR1, DCR1MGC149502, Decoy receptor 1, Decoy TRAIL receptor without death domain, LITMGC149501, Lymphocyte inhibitor of TRAIL, TNFRSF10C, TRAIL receptor 3, TRAIL receptor without an intracellular domain, TRAILR3, TRAIL-R3, TRAILR3TNF-related apoptosis-inducing ligand receptor 3, TRIDDCR1-TNFR, tumor necrosis factor receptor superfamily member 10C, tumor necrosis factor receptor superfamily, member 10c, decoy without anintracellular domain
Gene ID 8794
UniProt O14798
Pathways Apoptosis

Application Details

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Handling References for anti-TNFRSF10C antibody (ABIN4899000) Images back to top
Application Notes Flow Cytometry 0.25 μg/10^6 cells
CyTOF-ready
Restrictions For Research Use only

Handling

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details References for anti-TNFRSF10C antibody (ABIN4899000) Images back to top
Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS.
Buffer Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Preservative Without preservative
Storage 4 °C,-20 °C,-80 °C
Storage Comment Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt,-20°C to -70°C as supplied. 1 month,2°C to 8°C under sterile conditions after reconstitution. 6 months,-20°C to -70°C under sterile conditions after reconstitution.
Expiry Date 12 months

References for anti-TNFRSF10C antibody (ABIN4899000)

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details Handling Images back to top
Product cited in:

Neumann, Hasenauer, Pollak, Scheurich: "Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes." in: The Journal of biological chemistry, Vol. 289, Issue 23, pp. 16576-87, 2014

Moniri, Sun, Rayat, Dai, Ao, He, Verchere, Dai, Warnock: "TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells." in: Cancer gene therapy, Vol. 19, Issue 9, pp. 652-8, 2012 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Zauli, Rimondi, Celeghini, Milani, Secchiero: "Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)." in: Journal of cellular physiology, Vol. 222, Issue 2, pp. 357-64, 2009 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Stary, Klein, Kohlhofer, Koszik, Scherzer, Müllauer, Quendler, Kohrgruber, Stingl: "Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients." in: Blood, Vol. 114, Issue 18, pp. 3854-63, 2009 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: "Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells." in: Journal of cellular biochemistry, Vol. 104, Issue 2, pp. 595-605, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Toscano, Fajoui, Gay, Lalaoui, Parmentier, Chayvialle, Scoazec, Micheau, Abello, Saurin: "P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells." in: Oncogene, Vol. 27, Issue 30, pp. 4161-71, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Weinmann, Wischhusen, Demma, Naumann, Roth, Dasmahapatra, Weller: "A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis." in: Cell death and differentiation, Vol. 15, Issue 4, pp. 718-29, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Shankar, Chen, Ganapathy, Singh, Srivastava: "Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms." in: Molecular cancer therapeutics, Vol. 7, Issue 8, pp. 2328-38, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Braun, Fecker, Schwarz, Walden, Assaf, Dürkop, Sterry, Eberle: "Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells." in: The Journal of investigative dermatology, Vol. 127, Issue 10, pp. 2425-37, 2007 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Locklin, Federici, Espina, Hulley, Russell, Edwards: "Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis." in: Molecular cancer therapeutics, Vol. 6, Issue 12 Pt 1, pp. 3219-28, 2007 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Singh, Shankar, Srivastava: "HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma." in: Oncogene, Vol. 24, Issue 29, pp. 4609-23, 2005 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Images

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details Handling References for anti-TNFRSF10C antibody (ABIN4899000) back to top
Supplier Images
Flow Cytometry (FACS) image for anti-Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) (AA 1-221) antibody (ABIN4899000) Detection of TRAIL R3/TNFRSF10C in Human Blood Granulocytes by Flow Cytometry. Human ...
Flow Cytometry (FACS) image for anti-Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) (AA 1-221) antibody (ABIN4899000) Detection of TRAIL R3/TNFRSF10C in Human Blood Granulocytes by Flow Cytometry. Human ...